TNFSF10 and breast carcinoma: Intriguingly, the combination of both TQ+TRAIL re-balance the MDA and NO levels in MCF-7 and MDA-MB-231 cells, making this therapeutic combinatorial formula specific to kill breast cancer MCF-7 and MDA-MB-231 cells.